https://peptidepolicywatch.com/2026/11/03/telehealth-compounding-peptides-hhs-six-peptide-policy/Peptide Policy Watchen2026-11-03Hims & Hers names BPC-157 and TB-500 in its peptide plans as HHS's draft policy opens a compounding lane https://peptidepolicywatch.com/2026/11/03/peptides-for-veterans-act-hr-10212-what-it-would-do/Peptide Policy Watchen2026-11-03The PEPTIDES for Veterans Act (H.R. 10212): what the bill would actually do https://peptidepolicywatch.com/2026/11/03/peptide-serums-published-research-or-marketing-claims/Peptide Policy Watchen2026-11-03Do peptide serums have real research behind them, or just good marketing? https://peptidepolicywatch.com/2026/11/02/proprietary-blend-supplement-label-what-it-can-hide/Peptide Policy Watchen2026-11-02Proprietary blend on a supplement label: what it tells you and what it can leave out https://peptidepolicywatch.com/2026/11/02/oxytocin-first-synthetic-peptide-hormone-pitocin/Peptide Policy Watchen2026-11-02Oxytocin: the first peptide hormone made in a lab, and the medicine it became https://peptidepolicywatch.com/2026/11/02/anti-aging-longevity-peptide-claims-fda-ftc-rules/Peptide Policy Watchen2026-11-02Anti-aging and longevity peptide claims: what FDA and FTC rules actually say https://peptidepolicywatch.com/2026/11/02/2020-polypeptide-change-biologics-transition-40-amino-acids/Peptide Policy Watchen2026-11-02The 2020 "polypeptide" change: why insulin became a biologic and most peptides stayed drugs